As nurses and doctors worked to resuscitate a man passed out on the linoleum floor of the UCSF Parnassus Medical Center waiting room, the words of a ...
New drugs have made America’s deadliest cancer more treatable than ever. So why aren’t they reaching patients?
When patients with lower limb loss see physicians, they, along with the physicians, ignore that they’re an amputee in the ...
Terminally ill patients were promised access to experimental treatments, but the "right to try" exists mostly on paper.
If you are a doctor, the odds are that your patients think or do things you don’t agree with. Nearly half of Americans believe at least one health-related conspiracy theory, people routinely lie to ...
In May 2023, Joanna Loewenstein MD opened her concierge internal medicine practice in New York City, the first of its kind at Weill Cornell. Growing up in Long Island, Dr. Lowenstein remembers her dad ...
July 10 (Reuters) - Only one in four U.S. patients prescribed Novo Nordisk’s (NOVOb.CO), opens new tab Wegovy or Ozempic for weight loss were still taking the popular medications two years later, ...
Simnotrelvir is an oral 3-chymotrypsin–like protease inhibitor that has been found to have in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and potential efficacy ...
Recently, a long-standing patient came in for her routine office follow-up appointment for management of hypertension and arthritis. After a warm greeting, she told me there was a matter she needed to ...
Two cruise ship passengers who tested positive for hantavirus arrived in Atlanta on a specially-arranged flight Monday ...
"By embracing a DTC sales model, pharmaceutical companies and the patients that consume their drugs can essentially cut PBMs and other middlemen out of the picture," writes Pipes. Several Big Pharma ...
Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to produce the treatment for more patients. Gene therapies for rare diseases are ...